期刊文献+

重性精神疾病患者躯体共病的现状和挑战 被引量:8

原文传递
导出
摘要 重性精神疾病(Serious Mental Illness,SMI),如精神分裂症,双相情感障碍和重性抑郁障碍等不仅严重影响患者的人际关系、工作和独立生活的能力,同时也是造成患者躯体疾病患病率和死亡率不断升高的一个重要危险因素.目前,SMI患者的躯体健康状况十分严峻,躯体共病的发生率不断升高,已经成为21世纪医学研究的严峻挑战[1].
出处 《中华行为医学与脑科学杂志》 CAS CSCD 北大核心 2014年第2期181-183,共3页 Chinese Journal of Behavioral Medicine and Brain Science
基金 广东省自然科学基金资助项目(10151018004000001) 广东省科技攻关项目(2010B031900032)
  • 相关文献

参考文献38

  • 1Sartorius N. Comorbidity of mental and physical disorders: a main challenge to medicine in the 21st century[J] .Psychiatr Danub,2013, 25 Suppl 1 :4-5.
  • 2DE Hert M, Correll CU , BobesJ , et al.Physical illness in patients with severe mental disorders. 1. Prevalence, impact of medications and dis?parities in health care[J]. World Psychiatry ,2011 ,10(1) :52-77.
  • 3Shen HN , Lu CL, Yang HH. Increased risks of acute organ dysfunction and mortality in intensive care unit patients with schizophrenia: a na?tionwide population-based study[J] . Psychosom Med, 2011 ,73 ( 7) : 620-626.
  • 4Lawrence D, Kisely S. Inequalities in healthcare provision for people with severe mental illness[J] .J Psychopharrnacol, 2010, 24 (4 Sup?pl ) :61-68.
  • 5Zhao G,Ford ES,Dhingra S,et al.Depression and anxiety among US a?dults: associations with body mass index[J] . IntJObes (Lond), 2009 ,33( 2) :257-266.
  • 6Filik R, Sipos A, Kehoe PG, et al. The cardiovascular and respiratory health of people with schizophrenia[J] . Acta Psychiatr Scand , 2006 , 113( 4) :298-305.
  • 7Osborn DP, Levy G, Nazareth I, et al. Relative risk of cardiovascular and cancer mortality in people with severe mental illness from the U?nited Kingdom's General Practice Rsearch Database[J] . Arch Gen Psychiatry ,2007 ,64( 3) :242-249.
  • 8易峰,梅佳,苏旭江,毛静宇,张洋洋,甄莉丽.二甲双胍减轻第二代抗精神病药物所致精神分裂症患者体质量增高的Meta分析[J].中华行为医学与脑科学杂志,2013,22(3):221-224. 被引量:14
  • 9Merikangas AK, Mendola P, Pastor PN, et al. The association between major depressive disorder and obesity in US adolescents: results from the 2001-2004 National Health and Nutrition Examination Survey[Jl.J Behav Med,2012,35(2) : 149-154.
  • 10Scott KM, Bruffaerts R, Simon GE, et al. Obesity and mental disorders in the general population: results from the world mental health sur?veys[J] .IntJObes (Lond) ,2008,32(1) : 192-200.

二级参考文献29

  • 1李凌江 杨德森.生活质量综合评定问卷-74.中国心理卫生杂志,1999,:88-100.
  • 2沈渔邨.精神病学.北京:人民卫生出版社,2009:406.
  • 3汪向东 王希林 马弘.心理卫生评定量表手册.中国心理卫生杂志,1999,12:217-217.
  • 4张明园.精神科评定量表手册[M].长沙:湖南科学技术出版社,2003.35-39.
  • 5刘协和,李涛.牛津精神病学.成都:四川大学出版社,2010,361.
  • 6Meltzer HY,Burnett S,Bastani B,et al.Effects of six months of clozapine treatment on the quality of life of chronic schizophrenic patients.Hosp Comm Psychiatry,1990,41:892-897.
  • 7Xiberas X,Martinot JL,Mallet L,et al.In vivo extrastriatal and striatal 1D2 dopamine receptor blockade by amisulpride in schizophrenia.J Chin Psychophramaco1,2001,21:207-214.
  • 8Komossa K,Rummel-Kluge C,Hunger H,et al.Olanzapine versus other atypical antipsychotics for schizophrenia.Cochrane Database Syst Rev,2010,17:CD006654.
  • 9Seufert J,Liibben G,Dietrich K,et al. A comparison of the effects ofthiazolidinediones and metformin on metabolic control in patients withtype 2 diabetes mellitus. Clin Ther 2004,26 ;805-808.
  • 10Wiernsperger NF,Bailey CJ. The antihyperglycaemic effect of metform-in :therapeutic and cellular mechanisms. Drugs, 1999 ,58 :31 -39.

共引文献84

同被引文献78

  • 1汤军克,徐慧萍,李惠英,徐爱英,孙伯燕.减寿年数计算方法的比较[J].中国卫生统计,2004,21(4):222-223. 被引量:75
  • 2李春阳.精神分裂症住院患者合并躯体疾病临床分析[J].临床精神医学杂志,2006,16(2):100-101. 被引量:37
  • 3刘治军,傅得兴,孙春华,迟家敏,陈乃宏.抗抑郁药物相关的药物相互作用[J].中国药学杂志,2007,42(6):409-414. 被引量:16
  • 4中国成人血脂异常防治指南[J].中华心血管病杂志,2007,35(5):390-419. 被引量:5228
  • 5Sartorius N. Comorbidity of mental and physical disorders : a main challenge to medicine in the 21st century [ J]. Psychiatr Danub, 2013, 25 (Suppl. 1 ) :S4 -S5.
  • 6Gibb A, Deeks DE. Vortioxetine: First global approval[J]. Drugs, 2014, 74 : 135 - 145.
  • 7FDA. Brintellix (vortioxetine) tablets [ EB/OL ]. http ://www. rxlist. corrr/bHntellix - drug. btm, 2014 - 09 - 17.
  • 8Haggstrom L, Nielsen RZ, Danehenko N ,et al. A randomised, double - blind, study of vortioxetine versus agomelatine in adults with major depressive disorder (MDD) with inadequate response to SSRI/SNRI treatment [ J ]. Eur Neuropsychopharmacol , 2013,2 (Suppl.): S412.
  • 9Chen G, Lee R, Hcjer A. Pharmacokinetic Drug Interactions Invol- ving Vortioxetine (Lu AA21004 ), a Muhimodal Antidepressant [J]. Clin Drug lnvestigat, 2013, 33:727 -736.
  • 10Danchenko FN , Loft H, Rive B, et al. The effect of vortioxetine ( LU AA2100d.) on health - related quality of life (HRQOL) in pa- tients with major depressive disorder (MDD) [ J ]. Value Health, 2013,3 : 65.

引证文献8

二级引证文献45

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部